Simplex Trading
ZYME icon

Simplex Trading’s Zymeworks ZYME Stock Holding History

Simplex Trading’s Portfolio ZYME Stock Details ZYME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$135K Sell
5,400
-3,900
-42% -$92.3K ﹤0.01% 4744
2025
Q4 		$245K Sell
9,300
-23,900
-72% -$521K ﹤0.01% 4020
2025
Q3 		$567K Buy
33,200
+7,800
+31% +$112K ﹤0.01% 3669
2025
Q2 		$318K Sell
25,400
-5,700
-18% -$67.9K ﹤0.01% 4008
2025
Q1 		$370K Buy
31,100
+30,700
+7,675% +$419K ﹤0.01% 3731
2024
Q4 		$5K Sell
400
-1,000
-71% -$14K ﹤0.01% 7682
2024
Q3 		$17K Sell
1,400
-1,500
-52% -$16.3K ﹤0.01% 6820
2024
Q2 		$24K Sell
2,900
-18,600
-87% -$166K ﹤0.01% 6752
2024
Q1 		$226K Buy
21,500
+17,900
+497% +$199K ﹤0.01% 4717
2023
Q4 		$37K Buy
3,600
+200
+6% +$1.59K ﹤0.01% 6383
2023
Q3 		$21K Sell
3,400
-5,100
-60% -$37.7K ﹤0.01% 6594
2023
Q2 		$73K Sell
8,500
-22,100
-72% -$198K ﹤0.01% 5447
2023
Q1 		$276K Buy
30,600
+14,100
+85% +$123K ﹤0.01% 3942
2022
Q4 		$129K Sell
16,500
-47,900
-74% -$337K ﹤0.01% 4777
2022
Q3 		$396K Buy
64,400
+60,300
+1,471% +$363K ﹤0.01% 3742
2022
Q2 		$21K Buy
4,100
+2,500
+156% +$15.1K ﹤0.01% 7571
2022
Q1 		$10K Sell
1,600
-30,600
-95% -$273K ﹤0.01% 8912
2021
Q4 		$527K Buy
32,200
+30,100
+1,433% +$628K ﹤0.01% 3713
2021
Q3 		$78K Buy
2,100
+1,100
+110% +$36.6K ﹤0.01% 6965
2021
Q2 		$34K Buy
1,000
+983
+5,782% +$31.2K ﹤0.01% 8121
2021
Q1 		$53K Buy
17
+10
+143% +$406 ﹤0.01% 6549
2020
Q4 		$33K Sell
7
-108
-94% -$5.01K ﹤0.01% 6598
2020
Q3 		$535K Buy
115
+82
+248% +$2.82K ﹤0.01% 2919
2020
Q2 		$119K Sell
33
-33
-50% -$1.22K ﹤0.01% 4621
2020
Q1 		$234K Buy
66
+54
+450% +$2.21K ﹤0.01% 3423
2019
Q4 		$54K Hold
12
– – ﹤0.01% 5121
2019
Q3 		$29K Buy
12
+1
+9% +$25 ﹤0.01% 5529
2019
Q2 		$24K Buy
11
+6
+120% +$110 ﹤0.01% 5481
2019
Q1 		$8K Buy
+5
New +$78 ﹤0.01% 6296

Other funds holding ZYME

EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Simplex Trading's ZYME Position: Q1 2026 in Review

Simplex Trading reduced its Zymeworks (ZYME) stake by 97% in Q1 2026, selling an estimated $1.11M and leaving 1,336 shares worth $33.5K. The position accounts for ﹤0.01% of the portfolio, ranked #6278.

Simplex Trading first reported a position in ZYME in Q4 2018 and has held it in 25 quarters since. The position peaked at $1.79M in Q4 2019. 211 funds tracked by Wall St. Rank hold ZYME as of Q1 2026.

  • Simplex Trading held 1,336 shares of Zymeworks worth $33.5K as of Q1 2026.
  • Simplex Trading sold 46,704 Zymeworks shares in Q1 2026, an estimated $1.11M.
  • Zymeworks made up ﹤0.01% of Simplex Trading's portfolio in Q1 2026, its #6278 holding.
  • Simplex Trading first reported a position in Zymeworks in Q4 2018 and has held it in 25 quarters since.
  • Simplex Trading's Zymeworks position peaked at $1.79M in Q4 2019.
  • 211 funds tracked by Wall St. Rank held Zymeworks as of Q1 2026.

Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.